how long has tirzepatide been on the market Tirzepatide, active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, more tricks up its sleeve. Research out this week shows that it can do wonders FDA approves new version of

The program operates separately from the usual Part D coverage and payment system and is scheduled to run through December 31, 2027, according to the Centers for Medicare & Medicaid Services

Similarly, more than 40% of patients with type 2 diabetes treated with blood glucose-lowering agents do not reach their glycaemic goals [9, 10]

This article explores the clinical considerations, safety risks, and necessary precautions when using this triple-medication approach for metabolic health, and it may help to review what GLP-1 therapy is and how it works as you read

Weight them as individual directional signals, not outcome guarantees

A federal judge dismissed the case in November 2025, ruling the company did not show the groups held monopoly power over the competition